UNFI CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities...

Your unfiltered news center. ®

The world you see depends upon the news you get. ®

HOME

ARTS

RSS

Today's Date: June 9, 2023

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Tingo Group, Inc. (TIO) Investor • TEXAS CAPITAL ALERT: Bragar Eagel & Squire, P.C. is Investigating Texas Capital Bancshares, Inc. on Behalf of Texas Capital • Forbes names Sun Life U.S. a Best Employer for Diversity • A New Era of Three-Row Luxury: The First-Ever Lexus TX • ADVANCE AUTO PARTS ALERT: Bragar Eagel & Squire, P.C. is Investigating Advance Auto Parts, Inc. on Behalf of Advance Auto Pa • Providing LGBTQI+ people with a safe home in Canada • TIO EQUITY ALERT: ROSEN, A LONGSTANDING LAW FIRM, Encourages Tingo Group, Inc. Investors with Losses in Excess of $100K to Secur • Fairmont Mayakoba to host exclusive 2023 pride celebration • Ventas Realty, Limited Partnership Announces Upsize and Pricing of $750 Million of Exchangeable Senior Notes • Sophisticated Utility Vehicle: all-new 2024 Lexus GX Redefines SUV • AHF Applauds President Biden’s Strong Defense of LGBTQ+ Rights • CGTN: China stresses green development, ethnic unity in modernization drive • Influencers, Youth Mentorship Organizations and Concerned Citizens Make a Summer Plan to Stop the Violence in Chicago • Stallergenes Greer Showcases Clinical Relevance and Persisting Benefits of Its Allergen Immunotherapy Treatments at 2023 EAACI C • Saudi Arabia: Modern means of transportation for easier Hajj • SoftwareReviews Reveals the Top ESG Software Solutions That Enable Organizations to Build a Culture of Purpose and Sustainabilit • IgGenix Demonstrates Potential for an IgG4 Monoclonal Antibody-based Approach to Treating Peanut Allergy • Children's Miracle Network Hospitals® Celebrates 40th Anniversary with Celebrity Friends and Supporters • USCIB Releases Pride Month Statement, Supporting Equality and Inclusion • Fate ALERT: Bragar Eagel & Squire, P.C. is Investigating Fate Therapeutics, Inc. on Behalf of Long-Term Stockholders and Enc

UNFI CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against United Natural Foods, Inc.

LOS ANGELES , March 20 /Businesswire/ - Glancy Prongay & Murray LLP (“GPM”), announces that it has filed a class action lawsuit in the United States District Court for the Southern District of New York, captioned Sills v. United Natural Foods Inc., et al., Case No. 23-cv-02364, on behalf of persons and entities that purchased or otherwise acquired United Natural Foods, Inc. (“United Natural Foods” or the “Company”) (NYSE: UNFI) securities between March 10, 2021 and March 7, 2023, inclusive (the “Class Period”). Plaintiff pursues claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”).

Investors are hereby notified that they have 60 days from this notice to move the Court to serve as lead plaintiff in this action.

If you suffered a loss on your United Natural Foods investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit your contact information at www.glancylaw.com/cases/United-Natural-Foods-Inc/. You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at shareholders@glancylaw.com or visit our website at www.glancylaw.com to learn more about your rights.

On March 8, 2023, before the market opened, United Natural Foods announced its second quarter 2023 financial results, revealing a $6 million decline in gross profit, despite a 6% increase in net sales. The Company stated that its profits “were challenged as we did not repeat the significant level of procurement gains from rapidly accelerating inflation and inventory gains, due to supply chain volatility, that we experienced in the second quarter of last year.”

On this news, the Company’s stock price fell $11.49, or 28.1%, to close at $29.47 per share on March 8, 2023, thereby injuring investors.

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that, despite its cost saving Value Path initiative, United Natural Foods had not invested in improving its data management and related infrastructure; (2) that, as a result, the Company could not respond adequately to cost changes, such as inflationary pressure; (3) that, as a result, the Company could not appreciate the benefits of procurement gains and inventory gains achieved during fiscal 2022; (4) that, as a result of the foregoing, the Company’s profitability would be materially adversely impacted; and (5) and that as a result of the foregoing, Defendant’s positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

If you purchased or otherwise acquired United Natural Foods securities during the Class Period, you may move the Court no later than 60 days from this notice to ask the Court to appoint you as lead plaintiff. To be a member of the Class you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class. If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Charles Linehan, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to shareholders@glancylaw.com, or visit our website at www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.